Clinical Trial

Effect of Add-on L-Arginine Therapy on Heart Failure Patients

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Heart failure is considered one of the greatest challenges globally. There are various treatment strategies for heart failure. L-Arginine is an amino acid that was found to have beneficial effect on vasculature. This study aims to study the benefits and side effects of using L-arginine on the patients with ejection fraction \<40%
Trial Details
NCT Number NCT07394270
Lead Sponsor German University in Cairo
Collaborators: Ain Shams University
Conditions Heart Failure
Enrollment 200 participants
Start Date 2026-02
Primary Completion 2027-03 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-06